Conditions: Renal Disease
Keywords: Renal disease Contrast agent MRA
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 13
Healthy volunteers: no

Brief summary:
The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.

Detailed description:
Each participant will undergo first a TOF MRA followed by a Dotarem-enhanced MRA.

Arms:
arm 1: Each subject will receive one injection of Dotarem 0.2ml/kg. arm 2: Each subject will undergo a TOF Magnetic Resonance Angiography

Interventions: intervention 1: Dotarem intervention 2: Time of Flight
Intervention descriptions: intervention 1: Each subject will receive one injection of Dotarem 0.2ml/kg intervention 2: Each subject will undergo a TOF MRA

Protocol document: